Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Anti-Cancer Agents in Medicinal Chemistry|March 27, 2018
Synthesis and Anticancer Properties of Novel Truncated Carbocyclic Nucleoside AnaloguesBalija Sivakrishna, Sehbanul Islam, Amarendra Panda, et al.International Journal of Biological Macromolecules|July 4, 2006
Effects of pH and ionic strength on the assembly and bundling of FtsZ protofilaments: a possible role of electrostatic interactions in the bundling of protofilamentsTushar K Beuria, Jaimin H Shah, Manas K Santra, et al.Organic & Biomolecular Chemistry|March 10, 2020
Synthesis of artemisinic acid derived glycoconjugates and their anticancer studiesTharun K Kotammagari, Sayantan Paul, Ganesh K Barik, et al.Bioorganic & Medicinal Chemistry|June 19, 2024
Rutaecarpine-inspired scaffold-hopping strategy and Ullmann cross-coupling based synthetic approach: Identification of pyridopyrimidinone-indole based novel anticancer chemotypesMukul Yadav, Nibedita Roy, Kartik Mandal, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 20, 2021
Microtubule-targeting agents impair kinesin-2-dependent nuclear transport of β-catenin: Evidence of inhibition of Wnt/β-catenin signaling as an important antitumor mechanism of microtubule-targeting agentsAnuradha Kumari, Omprakash Shriwas, Shailendra Sisodiya, et al.Molecular Cell|October 27, 2009
Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expressionRajendra Kumar Palakurthy, Narendra Wajapeyee, Manas K Santra, et al.Bioorganic & Medicinal Chemistry Letters|March 31, 2015
Novel hybrid nocodazole analogues as tubulin polymerization inhibitors and their antiproliferative activitySangram S Kale, Ganesh S Jedhe, Sachin N Meshram, et al.Journal of Proteomics|August 30, 2019
XPO1 is a critical player for bortezomib resistance in multiple myeloma: A quantitative proteomic approachVenkatesh Chanukuppa, Debasish Paul, Khushman Taunk, et al.Biochemical Pharmacology|October 14, 2019
C12, a combretastatin-A4 analog, exerts anticancer activity by targeting microtubulesAnuradha Kumari, Shalini Srivastava, Rajesh K Manne, et al.RSC Advances|May 13, 2022
Synthesis and anticancer studies of Michael adducts and Heck arylation products of sesquiterpene lactones, zaluzanin D and zaluzanin C from Vernonia arboreaTushar R Valkute, Eswar K Aratikatla, Neha A Gupta, et al.Pageof 3